Start Date
July 31, 2001
Primary Completion Date
April 30, 2005
Study Completion Date
April 30, 2005
exatecan mesylate
gemcitabine hydrochloride
Memorial Sloan-Kettering Cancer Center, New York
New York Medical College, Valhalla
Nassau Hematology/Oncology PC, Lake Success
HemOnCare, P.C., Brooklyn
Mary Imogene Bassett Hospital, Cooperstown
Buffalo Medical Group, P.C., Williamsville
Lancaster Cancer Center, Lancaster
University of Pennsylvania Cancer Center, Philadelphia
Oncology-Hematology Associates, P.A., Clinton
Duke Comprehensive Cancer Center, Durham
N.W. Carolina Oncology & Hematology, P.A., Hickory
Peachtree Hematology and Oncology Consultants, P.C., Atlanta
Emory University School of Medicine, Atlanta
Central Georgia Hematology Oncology, P.C., Macon
MD Anderson Cancer Center Orlando, Orlando
nTouch Research, Melbourne
Sylvester Cancer Center, University of Miami, Miami
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Intouch Research, Huntsville
Providence Cancer Center, Mobile
Williamson Medical Center, Franklin
Sarah Cannon-Minnie Pearl Cancer Center, Nashville
Memorial Hospital Cancer Center - Chattanooga, Chattanooga
Family Cancer Center, Germantown
Jackson-Madison County General Hospital, Jackson
Mid-Ohio Oncology/Hematology, Inc., Columbus
Cleveland Clinic Cancer Center, Cleveland
Hope Center, Terre Haute
Providence Hospital Cancer Center, Southfield
UW Cancer Center Wausau Hospital, Wausau
Virginia Piper Cancer Institute, Minneapolis
Billings Oncology Associates, Billings
Great Falls Clinic, Great Falls
Lutheran General Cancer Care Center, Park Ridge
Midwest Hematology Oncology Consultants, Ltd., St Louis
St. Joseph Oncology, Inc., Saint Joseph
Scott and White Memorial Hospital, Temple
University of Colorado Cancer Center, Denver
Central Utah Medical Clinic, Provo
Arizona Clinical Research Center, Tucson
Nevada Cancer Center, Las Vegas
Pacific Shores Medical Group, Long Beach
Cancer and Blood Institute of the Desert, Rancho Mirage
Medical Oncology/Hematology, Gilroy
Sutter Cancer Center, Sacramento
Rainier Oncology, Puyallup
Yakima Regional Cancer Care Center, Yakima
California Cancer Care, Inc., Greenbrae
Medical Oncology and Hematology, P.C., Hamden
Cancer Research Center of Hawaii, Honolulu
Northwestern Memorial Hospital, Chicago
Harbor Hospital Center, Baltimore
St. Louis University Health Sciences Center, St Louis
Center for Cancer And Hematologic Disease, Cherry Hill
Hematology Oncology Associates, Morristown
Hematology and Oncology Group, Somerset
Summit Medical Group, P.A., Summit
State University of New York Health Sciences Center - Stony Brook, Stony Brook
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
Ireland Cancer Center, Cleveland
Medical Oncology Associates of Wyoming Valley, P.C., Kingston
Lifespan: The Miriam Hospital, Providence
Vanderbilt-Ingram Cancer Center, Nashville
Joe Arrington Cancer Research and Treatment Center, Lubbock
Cancer Therapy and Research Center, San Antonio
Intermountain Hematology/Oncology Associates, Inc., Salt Lake City
Cross Cancer Institute, Edmonton
CancerCare Manitoba, Winnipeg
Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury
Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor
Queen Elizabeth Hospital, PEI, Charlottetown
CHUM Hopital Saint-Luc, Montreal
Montreal General Hospital, Montreal
Veterans Affairs Medical Center - San Juan, San Juan
Lead Sponsor
Daiichi Sankyo
INDUSTRY